|Study Description:||The goal of this clinical research study is to find the highest tolerable dose |
of the combination of ipilimumab and imatinib that can be given to patients
with advanced cancer. The safety of this drug combination will also be studied.
Ipilimumab is designed to increase the immune system's ability to fight cancer.
Imatinib is designed to bind to certain proteins on the tumor cells, which may
prevent the cells from growing.